It's no secret.
Investors can expect Placements and as Joel said at the Presentations, investors can expect CR's. This biotech business is capital-intensive.
If you want further information on this, then drop Joel an email.
Good luck @mattyedw
Don't rely on poster information, or make any decisions from posts, confirm it via email. Outside of HC.
